These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29080264)

  • 1. Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations.
    Sicco E; Báez J; Margenat J; García F; Ibarra M; Cabral P; Moreno M; Cerecetto H; Calzada V
    Chem Biol Drug Des; 2018 Mar; 91(3):747-755. PubMed ID: 29080264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging.
    Rockey WM; Huang L; Kloepping KC; Baumhover NJ; Giangrande PH; Schultz MK
    Bioorg Med Chem; 2011 Jul; 19(13):4080-90. PubMed ID: 21658962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies.
    Sicco E; Baez J; Ibarra M; Fernández M; Cabral P; Moreno M; Cerecetto H; Calzada V
    Cancer Biother Radiopharm; 2020 May; 35(4):262-270. PubMed ID: 32407201
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor targeting by an aptamer.
    Hicke BJ; Stephens AW; Gould T; Chang YF; Lynott CK; Heil J; Borkowski S; Hilger CS; Cook G; Warren S; Schmidt PG
    J Nucl Med; 2006 Apr; 47(4):668-78. PubMed ID: 16595502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
    J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.
    Calzada V; Moreno M; Newton J; González J; Fernández M; Gambini JP; Ibarra M; Chabalgoity A; Deutscher S; Quinn T; Cabral P; Cerecetto H
    Bioorg Med Chem; 2017 Feb; 25(3):1163-1171. PubMed ID: 28089349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-specific internalization study of an aptamer from whole cell selection.
    Xiao Z; Shangguan D; Cao Z; Fang X; Tan W
    Chemistry; 2008; 14(6):1769-75. PubMed ID: 18092308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
    Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
    Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals.
    Farzin L; Shamsipur M; Moassesi ME; Sheibani S
    Bioorg Med Chem; 2019 Jun; 27(12):2282-2291. PubMed ID: 30502114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional aptamer-silver conjugates as theragnostic agents for specific cancer cell therapy and fluorescence-enhanced cell imaging.
    Li H; Hu H; Zhao Y; Chen X; Li W; Qiang W; Xu D
    Anal Chem; 2015 Apr; 87(7):3736-45. PubMed ID: 25686206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted-Lymphoma Drug Delivery System Based on the Sgc8-c Aptamer.
    Sicco E; Cerecetto H; Calzada V; Moreno M
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers as radiopharmaceuticals for nuclear imaging and therapy.
    Gijs M; Aerts A; Impens N; Baatout S; Luxen A
    Nucl Med Biol; 2016 Apr; 43(4):253-71. PubMed ID: 26746572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity.
    Mittelberger F; Meyer C; Waetzig GH; Zacharias M; Valentini E; Svergun DI; Berg K; Lorenzen I; Grötzinger J; Rose-John S; Hahn U
    RNA Biol; 2015; 12(9):1043-53. PubMed ID: 26383776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer.
    Borbas KE; Ferreira CS; Perkins A; Bruce JI; Missailidis S
    Bioconjug Chem; 2007; 18(4):1205-12. PubMed ID: 17583928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in Aptamer Discovery Technologies.
    Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
    Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.